Strobeck Matthew — SEC Form 4 filings
SEC reporting owner CIK 1377832. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-02.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-25 to 2026-06-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 4 filings — 290,000 shares, $502,460 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 10,000 shares @ $23.96 ($239,586) in QuidelOrtho Corp, filed 2026-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| QuidelOrtho Corp (QDEL) | Director | 6 | 1 leg · 10,000 sh · $239,586 | — | 8 |
| ELUTIA INC. (ELUT) | — | 1 | 5 legs · 140,000 sh · $206,958 | — | — |
| BIODESIX INC (BDSX) | Director | 5 | 2 legs · 40,000 sh · $55,916 | — | 12 |
| Accelerate Diagnostics, Inc (AXDX) | Director | 1 | 1 leg · 100,000 sh | — | 1 |
Form 4 filings — Strobeck Matthew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-02 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 6,829 @ $0 · Option exercise (M): 6,829 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | QuidelOrtho Corp (QDEL) | Purchase (P): 10,000 @ $23.96 | EDGAR |
| 2026-01-06 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 6,804 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 6,829 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 4,929 @ $0 · Option exercise (M): 4,929 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 80,525 (derivative) @ $0 · Grant/award (A): 42,010 (derivative) @ $0 | EDGAR |
| 2024-11-06 | 4 | BIODESIX INC (BDSX) | Purchase (P): 4,000 @ $1.40 · Purchase (P): 36,000 @ $1.40 | EDGAR |
| 2024-05-29 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 2,416 @ $0 · Option exercise (M): 2,416 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | QuidelOrtho Corp (QDEL) | Grant/award (A): 4,929 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | BIODESIX INC (BDSX) | Option exercise (M): 52,160 · Option exercise (M): 295,680 · Grant/award (A): 53,726 (derivative) @ $0 · Grant/award (A): 37,050 (derivative) @ $0 · Option exercise (M): 1,304 (derivative) @ $0 · Option exercise (M): 7,392 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | BIODESIX INC (BDSX) | Grant/award (A): 1,304 (derivative) @ $46 · Grant/award (A): 7,392 (derivative) @ $46 | EDGAR |
| 2024-02-20 | 4/A | ELUTIA INC. (ELUT) jointly with Birchview Capital, LP, Birchview Fund LLC | Purchase (P): 100,000 @ $1.49 · Purchase (P): 10,000 @ $1.49 · Purchase (P): 18,000 @ $1.35 · Purchase (P): 2,000 @ $1.35 · Purchase (P): 10,000 @ $1.59 | EDGAR |
| 2024-01-25 | 4 | Accelerate Diagnostics, Inc (AXDX) | Purchase (P): 100,000 · Purchase (P): 100,000 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1377832 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →